RESUMO
Intestinal transplantation is no longer an experimental procedure and is the treatment of choice for patients with irreversible intestinal failure that cannot be maintained on total parenteral nutrition (TPN). The intestine was a forbidden organ to be transplanted in humans until the 1980s due to its rich lymphoid content that precipitates either host-versus-graft or graft-versus-host alloreactivity.
RESUMO
During the past 30 years orthotopic liver transplantation (OLTx) has become a highly successful form of therapy, and as of this writing it is being performed at more than 100 institutions in the U.S., and a similar number in Europe. This is testimony to the great advances achieved in this field since the 1960s and 1970s, when there were essentially only two places actively engaged in liver transplantation. Essential to its success have been the technical refinements introduced during the last three decades, which have allowed many surgeons around the world to be able to do the procedure safely. Liver transplantation is still considered as one of the most complex operations, and therefore the margin of error is small and attention to technical detail is crucial to a satisfactory outcome. This is magnified in importance since OLTx, unlike kidney, heart, pancreas and intestinal transplantation, lacks a back-up system, such as dialysis, ventricular assist device, insulin or total parenteral nutrition. Thus, the smallest mistake in the surgical management of the patient may prove fatal.
RESUMO
Stenosis of the portal vein anastomosis occurred in three pediatric patients seven to 42 months after transplantation. Dominant symptoms were those of portal hypertension and hypersplenism. Diagnosis was made by angiography. Successful surgical reconstruction was possible in all three patients.